Money Concepts Capital’s 10x Genomics TXG Stock Holding History

Money Concepts Capital’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-138	Closed	-$5.03K	–	2710
2022 Q4	$5.03K	Sell	138 -7,401	-98%	-$242K	﹤0.01%	2342
2022 Q3	$215K	Buy	7,539 +161	+2%	+$6.13K	0.01%	413
2022 Q2	$346K	Buy	7,378 +297	+4%	+$15.4K	0.03%	328
2022 Q1	$539K	Buy	7,081 +4,275	+152%	+$374K	0.03%	422
2021 Q4	$418K	Buy	+2,806	New	+$430K	0.04%	344
2021 Q1	$589K	Buy	3,253 +1,167	+56%	+$202K	0.05%	287
2020 Q4	$295K	Buy	+2,086	New	+$303K	0.03%	363

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Money Concepts Capital's TXG Position: Q1 2023 in Review

Money Concepts Capital sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 138 shares — an estimated $5.03K sold.

Money Concepts Capital first reported a position in TXG in Q4 2020 and held it in 7 quarters. The position peaked at $589K in Q1 2021. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

Money Concepts Capital reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
Money Concepts Capital sold 138 10x Genomics shares in Q1 2023, an estimated $5.03K.
Money Concepts Capital first reported a position in 10x Genomics in Q4 2020 and held it in 7 quarters.
Money Concepts Capital's 10x Genomics position peaked at $589K in Q1 2021.
258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on Money Concepts Capital's 13F filing for Q1 2023, filed 1 May 2023.